AVE 0.00% 0.2¢ avecho biotechnology limited

needle less dental surgery, page-5

  1. 207 Posts.
    lightbulb Created with Sketch. 10
    Worthy competitor yes, but that does not mean POH will not have a role to play if the insulin patch is ever commercialised. The patch will be ideal for those diabetics who are well managed by diet and exercise and can rely on a certain set amount of insulin entering the body each day. In the case of my brother, he is referrred to as a brittle diabetic where the amount of insulin he requires each day can vary greatly. I am certainly not an expert in this area but I do not think a patch would be appropriate for my brother.

    The vast number of different applications that TPM can be applied offers huge skyhigh potential earnings for POH, no doubt about that.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.